Table 3.
The distribution of various genotypes in our Hungarian myositis patients and healthy individuals (representing the cases with a P value less than .05).
| BB | Bb | bb | ||
|---|---|---|---|---|
| Number of male myositis patients | 1 | 15 | 4 | P value < .001 |
| Number of female myositis patients | 16 | 20 | 33 | |
|
| ||||
| BB | Bb | bb | ||
|
| ||||
| Number of male myositis patients | 1 | 15 | 4 | P value = .0323 |
| Number of control individuals | 16 | 40 | 37 | |
|
| ||||
| BB | Bb | bb | ||
|
| ||||
| Number of male myositis patients | 1 | 15 | 4 | P value = .0176 |
| Number of control male individuals | 8 | 15 | 18 | |
|
| ||||
| TT | Tt | tt | ||
|
| ||||
| Number of male myositis patients | 5 | 12 | 3 | P value = .037 |
| Number of female myositis patients | 34 | 20 | 15 | |
|
| ||||
| FF | Ff | ff | ||
|
| ||||
| Number of MAA positive patients | 2 | 14 | 5 | P value = .0033 |
| Number of control individuals | 31 | 33 | 29 | |
|
| ||||
| AA | Aa | aa | ||
|
| ||||
| Number of female myositis patients | 28 | 23 | 18 | P value = .0398 |
| Number of control female individuals | 11 | 28 | 13 | |